SAB Biotherapeutics Inc
(NAS:SABS)
$
3.567
+0.020 (+0.56%)
Market Cap: 272.75 Mil
Enterprise Value: 171.53 Mil
PE Ratio: 0
PB Ratio: 1.19
GF Score: 26/100 SAB Biotherapeutics Inc (SABS) Transcripts
- 1